CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth Introduces 2019 FORE-SIGHT sales guidance BRANFORD, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the three and 12 months ended December 31, 2018. The Company expects net sales from continuing operations for the fourth quarter of 2018 to be approximately $5.8 mill...
CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5 BRANFORD, Conn., Nov. 28, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 11th Annual LD Micro Main Event Conference on Wednesday, December 5, 2018, at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will be available for one-on-one m...
CASMED Reports Third-Quarter 2018 Financial Results FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (“CASMED” or the “Company”), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, today reported financial results for the three and nine months ended September 30, 2018. Net sales from continuing operations for the third quarter of 2018 were $5.4 ...
CASMED to Report Third-Quarter 2018 Financial Results and Hold Conference Call on October 31 BRANFORD, Conn., Oct. 24, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the third quarter of 2018 on Wednesday, October 31. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day. Conference call dial-in information is as follows: U.S. callers: (800) 608-8202 International callers: ...
CASMED Reports Second Quarter 2018 Financial Results Achieves 20% U.S. FORE-SIGHT® sales growth, expands gross margin, narrows operating loss Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Aug. 02, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (“CASMED” or the “Company”), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, today reported financial results for the three and six months ended June 30, 2018. Net sales from continuing operations for the second quarter of 2018 were $5.3 million, up 16% from $4...
CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2 BRANFORD, Conn., July 27, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the second quarter of 2018 on Thursday, August 2. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day. Conference call dial-in information is as follows: U.S. callers: (800) 608-8202 International callers: (702) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.